Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Church

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
ESMO Open|November 21, 2020
Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancerChristian H Bergsland, Jarle Bruun, Marianne G Guren, et al.
The Lancet. Oncology|August 14, 2022
A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation studyAndreas Kleppe, Ole-Johan Skrede, Sepp De Raedt, et al.
Oncoimmunology|March 28, 2017
Immunological profiling of molecularly classified high-risk endometrial cancers identifies <i>POLE</i>-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibitionFlorine A Eggink, Inge C Van Gool, Alexandra Leary, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancerInge C Van Gool, Ellen Stelloo, Remi A Nout, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiativeEllen Stelloo, Tjalling Bosse, Remi A Nout, et al.
International Journal of Cancer|January 12, 2026
Outcomes from the English National Lynch Syndrome transformation projectKevin J Monahan, Paul Fleming, Neil A J Ryan, et al.
Cancers|June 10, 2023
Non-Canonical Activin A Signaling Stimulates Context-Dependent and Cellular-Specific Outcomes in CRC to Promote Tumor Cell Migration and Immune ToleranceMark B Wiley, Jessica Bauer, Kunaal Mehrotra, et al.
BMJ Oncology|January 31, 2025
The English National Lynch Syndrome transformation project: an NHS Genomic Medicine Service Alliance (GMSA) programmeKevin J Monahan, Neil Ryan, Laura Monje-Garcia, et al.
Cell Reports. Medicine|September 18, 2024
Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancerMarta Nowak, Faiz Jabbar, Ann-Katrin Rodewald, et al.
European Journal of Cancer (Oxford, England : 1990)|May 29, 2024
Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national expertsJulien Taieb, Debora Basile, Jenny Seligmann, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
ESMO Open|November 21, 2020
Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancerChristian H Bergsland, Jarle Bruun, Marianne G Guren, et al.
The Lancet. Oncology|August 14, 2022
A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation studyAndreas Kleppe, Ole-Johan Skrede, Sepp De Raedt, et al.
Oncoimmunology|March 28, 2017
Immunological profiling of molecularly classified high-risk endometrial cancers identifies <i>POLE</i>-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibitionFlorine A Eggink, Inge C Van Gool, Alexandra Leary, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancerInge C Van Gool, Ellen Stelloo, Remi A Nout, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2015
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiativeEllen Stelloo, Tjalling Bosse, Remi A Nout, et al.
International Journal of Cancer|January 12, 2026
Outcomes from the English National Lynch Syndrome transformation projectKevin J Monahan, Paul Fleming, Neil A J Ryan, et al.
Cancers|June 10, 2023
Non-Canonical Activin A Signaling Stimulates Context-Dependent and Cellular-Specific Outcomes in CRC to Promote Tumor Cell Migration and Immune ToleranceMark B Wiley, Jessica Bauer, Kunaal Mehrotra, et al.
BMJ Oncology|January 31, 2025
The English National Lynch Syndrome transformation project: an NHS Genomic Medicine Service Alliance (GMSA) programmeKevin J Monahan, Neil Ryan, Laura Monje-Garcia, et al.
Cell Reports. Medicine|September 18, 2024
Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancerMarta Nowak, Faiz Jabbar, Ann-Katrin Rodewald, et al.
European Journal of Cancer (Oxford, England : 1990)|May 29, 2024
Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national expertsJulien Taieb, Debora Basile, Jenny Seligmann, et al.
Pageof 7